Detection of Epithelial Growth Factor Receptor Mutations in Cerebrospinal Fluid from Patients with Lung Adenocarcinoma Suspected of Neoplastic Meningitis
Open Access
- 1 July 2011
- journal article
- research article
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 6 (7) , 1215-1220
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- EGFR-TKI and lung adenocarcinoma with CNS relapse: interest of molecular follow-upEuropean Respiratory Journal, 2009
- EGFR mutation status in tumour-derived DNA from pleural effusion fluid is a practical basis for predicting the response to gefitinibBritish Journal of Cancer, 2006
- Successful re-treatment with gefitinib for carcinomatous meningitis as disease recurrence of non-small-cell lung cancerLung Cancer, 2006
- Biological and clinical implications of EGFR mutations in lung cancerInternational Journal of Clinical Oncology, 2006
- Neoplastic MeningitisThe Neurologist, 2006
- Gefitinib response of erlotinib-refractory lung cancer involving meninges—role of EGFR mutationNature Clinical Practice Oncology, 2006
- Gefitinib is also active for carcinomatous meningitis in NSCLCLung Cancer, 2005
- EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinibProceedings of the National Academy of Sciences, 2004
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004